[128] By contrast, other DAT inhibitors including bupropion have not been observed to show this effect.[129] These observations have prompted the hypothesis that methylphenidate may act as a "DAT inverse agonist" or "adverse allosteric modifier in the DAT" by reversing the way of your dopamine efflux by the DAT at greater dosages.[130]Inform your H